Kentucky’s Hospital Cannabis Problem exposes the gap between medical cannabis approval and bedside access. Kentucky now recognizes terminal illness in its program. However, hospitals, hospices, nursing homes, and other care settings may still decide whether patients can use cannabis where pain, fear, and end-of-life care are happening.
Prohibition Is Running Out of Voters
Pew’s May 26, 2026 report says only 11 percent of U.S. adults want marijuana illegal in all cases. Pot Culture Magazine examines what that means for cannabis legalization, federal marijuana law, employment testing, immigration policy, banking barriers, and the drug war machinery still protecting prohibition after the public moved on.
Louisiana Rebuilds the Weed War
Louisiana says HB 568 protects schools. Critics see something older beneath the language: another expansion of marijuana enforcement through invisible school-zone boundaries. As lawmakers rebuild cannabis penalties around geography and fear, the state’s long relationship with punishment politics comes roaring back into view.
MISS. LIMITS MEDICAL CANNABIS WHERE IT MATTERS MOST
Mississippi maintains strict limits on medical cannabis after Governor Tate Reeves vetoed expansion bills on March 26, 2026. Patients remain unable to use cannabis in hospitals while eligibility and access rules stay tightly controlled. This feature examines what the veto blocks, how it affects patients, and what it means for the state’s growing cannabis market.
The Study That Pretends Cannabis Does Nothing
A new cannabis study claims marijuana does nothing for anxiety, depression, or PTSD. The reality is far more complicated. Decades of federal restrictions, limited research access, and synthetic substitutes have shaped the science. This breakdown exposes how incomplete data and selective interpretation continue to drive misleading headlines about cannabis and mental health.
Reefer Report Card Vol. 32: Kicking the Can Again
This week’s Reefer Report Card tracks a familiar pattern in cannabis policy: delay dressed as progress. Federal lawmakers punted again on hemp regulation, states flirted with dismantling legal markets, and patients were left waiting. Oversight weakened, accountability faded, and reform stalled. Another week in weed, graded.